Abstract: Perinatal HBV transmission is common in South East
Introduction
Viral hepatitis is the most common cause of jaundice in pregnancy. Perinatal transmission from mothers infected with HBV (i.e. positive for HBsAg) to the newborn infants is a major source of HBV infections in many countries. Three possibilities of transmission of HBV from carrier mothers to infants are suggested (a) transplacental transmission of HBV in utero (antenatal transmission), (b) natal transmission during delivery; (c) postnatal transmission from mother to infants during childcare or through breast milk (Schweitzer et al., 1972; Anderson et al., 1975) . In pregnancy hepatitis, the immune alterations in pregnancy may modify the dynamics of the disease. The problem is not only to the mother but also pertains to the offspring. The risk for the mother includes development of acute liver failure or fulminant hepatitis characterized by encephalopathy with or without coagulopathy. (WHO, 2001) Till date, published reports from South India have documented HBV as the major causative agent of viral hepatitis in the adults and children in general. It is reported and estimated that 22,000 pregnant women in the United States get infected with hepatitis B virus, which necessitated hepatitis B vaccination of the newborn mandatory in the United States. Perinatal HBV transmission is common in SouthEast Asia. The infants of the mothers, who are carrying both HBsAg and HBeAg, have the highest risk of acquiring the HBV infection by the perinatal route. It has been estimated that in Asia, perinatal transmission accounts for approximately 25-30% of the carrier pool. (CDC, 1996) .The over all risk may vary from one population to another, depending on the prevalence of HBeAg positivity in the pregnant women.
With this background information, this study was aimed to bring about authenticated documentation on impact of preventive measures by vaccination that are essential features to plan and implement health measures package in a country.
II. Materials and Methods
schedule was maintained; every mother was asked to return within 3 days of the target date and those who did not, were visited at their homes by Field visitors, Microbiologist and Clinician. All the babies born to Asymptomatic HBsAg positive mothers received three 0.5ml each doses of Hepatitis B vaccine by intramuscular injection in the lateral aspect of the thigh. At birth, as first dose second dose at 1 month after birth and the third dose at sixth month after birth.
III. Results
87 Mother / Child pairs completed one year follow up and were analyzed for vertical / perinatal transmission of HBV inspite of HBV vaccination.
6.8% (6/87) of these infants reached the status of chronic HBV infection from their infected mothers after 12 months follow-up. Of these 3 infants were born to HBeAg and HBV-DNA positive mothers and continued to be positive for HBsAg from birth till 12 th month. Simultaneously, three other infants who were negative for HBsAg from birth till 2 nd month became positive for HBsAg at 3 rd month and continued to be positive till 12 th month. Of these three infants, one was borne to HBsAg positive HBeAg / anti-HBe negative mother and 2 were borne to anti-HBe positive mothers. All these mothers were HBV-DNA positive.
IV. Discussion
Rate of chronic HBV infection in infants increases with maternal virus load. Children born to HBeAg / HBV-DNA positive mothers are said to have greater risk of acquiring HBV if no vaccine is given at birth. Even with vaccine it is said that the exposure of infants with immature immune system the large quantities of viral DNA may contribute to their inability to resolve HBV infection (Robert et al., 1994) .
In the present study a 12-month follow-up of children born to hepatitis B positive mothers, given full course of vaccination resulted in six of the infants acquiring HBV inspite of completing the vaccination process. Analysis of HBV marker profile of the markers who have transmitted the virus to the infants the following. 1) Of the six infants who had acquired HBV, 3 of them were born to HBeAg positive mothers (3/22-13.6%) and (2/65-3%) and one was born to a mother who was negative for HBeAg and anti -HBe but positive for HBsAg alone. These observations confirm the hypothesis of Burk et al., (1994) who have stated that the quantity of HBV in terms of concentration of circulating maternal viral DNA to which the infants are exposed is likely to decide the occurrence of chronic carrier state in the infants born to them.
It is amazed that the children born to HBeAg positive and HBV-DNA positive mothers may have to be given both hepatitis B vaccine and HBIG immediately after birth to obtain 100% success rate in preventing perinatal transmission.
Active vaccination has remained as the most effective way to control hepatitis B virus. Administration of vaccine immediately after birth is effective in preventing the transmission from a hepatitis B e antigenpositive mother in approximately 70% of cases. This rate may be increased to greater than 90% if the vaccine is accompanied by simultaneous administration of hepatitis B immunoglobulin (HBIG) ( 
V. Conclusion
Among the Mother / Child pairs analysed, 6.8% (6/87) of the infants developed chronic HBV infection in spite of hepatitis B vaccination all the children by acquiring HBV from their infected mothers as confirmed by twelve months of follow-up. The aim of the study is to bring about authenticated documentation on pregnancy hepatitis, maternal and fetal outcome in pregnancy hepatitis, transmission pattern from mother to child in asymptomatic viral infected mothers and impact of preventive measures by vaccination that are essential features to plan and implement health measures package in a country, Such comprehensive documentation are generally not available in developing countries and especially in India.
